1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Market Overview
5.3 Porter’s Five Force Analysis
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Degree of Competition
5.3.4 Threat of Substitution
5.3.5 Threat of New Entrants
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Demographic Shift and Impact of Prevalence of Eye Disease
6.1.2 Availability of New Drugs and Devices
6.1.3 Growth in Cataract Volume
6.2 Market Restraints
6.2.1 Increasing Healthcare Costs
6.2.2 Economic Slowdown in Developed Markets
6.2.3 Strict FDA Guidelines for Drug Approval
6.3 Opportunities
6.4 Challenges
7. Market Segmentation
7.1 Surgical Devices
7.1.1 Glaucoma Surgery Devices
7.1.1.1 Glaucoma Drainage Devices
7.1.1.2 Glaucoma Lasers
7.1.1.3 Glaucoma Stents and Implants
7.1.1.4 Others
7.1.2 Cataract Surgery Devices
7.1.2.1 Intraocular Lenses
7.1.2.2 Phacoemulsification Devices
7.1.2.3 Ophthalmic Viscoelastic Devices
7.1.3 Refractive Surgery Devices
7.1.3.1 Microkeratomers
7.1.3.2 Lasers
7.1.4 Vitreoretinal Surgery Devices
7.1.4.1 Photocoagulation Lasers
7.1.4.2 Illumination Devices
7.1.4.3 Vitrectomy Machines & Packs
7.1.4.4 Other Vitreoretinal Surgery Devices
7.1.5 Diagnostic & Monitoring Devices
7.1.5.1 Fundus Cameras
7.1.5.2 Ophthalmoscopes
7.1.5.3 Retinoscopes
7.1.5.4 Keratometers
7.1.5.5 Tonometers
7.1.5.6 Wavefront Aberrometers
7.1.5.7 Corneal Topography
7.1.5.8 Autorefractors
7.1.5.9 Visual Field Analyzers
7.1.5.10 Slit Lamps
7.1.5.11 Optical Coherence Tomography Scanners
7.1.5.12 Ophthalmic Ultrasound Imaging Systems
7.1.5.13 Other Diagnostic & Monitoring Devices
7.2 By Drugs
7.2.1 Anti Glaucoma Drugs
7.2.2 Ophthalmic Infection Drugs
7.2.3 Ophthalmic Inflammation Drugs
7.2.4 Ophthalmic Lubricants
7.2.5 Mydriasis Drugs
7.2.6 Ophthalmic Swelling
7.3 By Geography
7.3.1 North America
7.3.1.1 US
7.3.1.2 Canada
7.3.1.3 Mexico
7.3.2 Europe
7.3.2.1 Germany
7.3.2.2 UK
7.3.2.3 France
7.3.2.4 Italy
7.3.2.5 Spain
7.3.2.6 Rest Of Europe (RoE)
7.3.3 Asia Pacific
7.3.3.1 Japan
7.3.3.2 China
7.3.3.3 India
7.3.3.4 South Korea
7.3.3.5 Australia
7.3.3.6 Rest Of Asia Pacific
7.3.4 The Middle East & Africa
7.3.4.1 GCC Countries
7.3.4.2 South Africa
7.3.4.3 Rest Of Middle East & Africa
7.3.5 South America
7.3.5.1 Brazil
7.3.5.2 Argentina
7.3.5.3 Rest Of South America
8. Competitive Landscape
8.1 Mergers & Acquisitions
8.2 Agreements, Collaborations & Partnerships
8.3 New Product Launches
9. Key Players
9.1 Carl Zeiss Meditec AG
9.2 Alcon Inc.
9.3 Johnson And Johnson
9.4 Topcon Corporation
9.5 Nidek Co. Ltd.
9.6 Haag-Streit Group
9.7 Ziemer Ophthalmic Systems AG
9.8 Essilor International S.A.
9.9 Bausch & Lomb Inc.
10. Future of the Market

CARL ZEISS MEDITEC AG
ALCON INC.
JOHNSON AND JOHNSON
TOPCON CORPORATION
NIDEK CO. LTD.
HAAG-STREIT GROUP
ZIEMER OPHTHALMIC SYSTEMS AG
ESSILOR INTERNATIONAL S.A.
BAUSCH & LOMB INC.
amongst others.